Lentiviral vectors for cancer immunotherapy transforming infectious particles into therapeutics
Target ArticleEdit
Lentiviral vectors for cancer immunotherapy transforming infectious particles into therapeutics; K Breckpot, JL Aerts, K Thielemans; 2007; doi_citing_unknown
RetractionEdit
RETRACTED ARTICLE: How can SLCA influence change to a product’s life cycle and who listens to the impacts of an SLCA?; Choi, Hee Sun; ; 2016-4-01
Citation pieceEdit
Note: Open to append information.